Cargando…
Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418649/ https://www.ncbi.nlm.nih.gov/pubmed/32871524 http://dx.doi.org/10.1016/j.ejca.2020.07.030 |
| _version_ | 1783569730241560576 |
|---|---|
| author | Montrone, Michele Catino, Annamaria Palmieri, Vincenzo O. Longo, Vito Galetta, Domenico |
| author_facet | Montrone, Michele Catino, Annamaria Palmieri, Vincenzo O. Longo, Vito Galetta, Domenico |
| author_sort | Montrone, Michele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7418649 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74186492020-08-12 Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib Montrone, Michele Catino, Annamaria Palmieri, Vincenzo O. Longo, Vito Galetta, Domenico Eur J Cancer Letter to the Editor Elsevier Ltd. 2020-10 2020-08-11 /pmc/articles/PMC7418649/ /pubmed/32871524 http://dx.doi.org/10.1016/j.ejca.2020.07.030 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Montrone, Michele Catino, Annamaria Palmieri, Vincenzo O. Longo, Vito Galetta, Domenico Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title | Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title_full | Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title_fullStr | Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title_full_unstemmed | Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title_short | Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| title_sort | favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418649/ https://www.ncbi.nlm.nih.gov/pubmed/32871524 http://dx.doi.org/10.1016/j.ejca.2020.07.030 |
| work_keys_str_mv | AT montronemichele favourableoutcomeofcoronavirusdisease2019inapatientwithanaplasticlymphomakinasepositivenonsmallcelllungcancerreceivingalectinib AT catinoannamaria favourableoutcomeofcoronavirusdisease2019inapatientwithanaplasticlymphomakinasepositivenonsmallcelllungcancerreceivingalectinib AT palmierivincenzoo favourableoutcomeofcoronavirusdisease2019inapatientwithanaplasticlymphomakinasepositivenonsmallcelllungcancerreceivingalectinib AT longovito favourableoutcomeofcoronavirusdisease2019inapatientwithanaplasticlymphomakinasepositivenonsmallcelllungcancerreceivingalectinib AT galettadomenico favourableoutcomeofcoronavirusdisease2019inapatientwithanaplasticlymphomakinasepositivenonsmallcelllungcancerreceivingalectinib |